Physician profile
Roy Kim
NPI 1275545543
$4,725.73
in general payments reported to CMS, 2019-2025
11 companies · $283 in 2025
The $283 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $650 · 2020: $97.89 · 2021: $1,823 · 2022: $972 · 2023: $553 · 2024: $347 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,174 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,174.07 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,772.46 | 2019-2022 | |
| Abbvie INC. | $929.31 | 2019-2025 | |
| Musculoskeletal Transplant Foundation INC. | $244.20 | 2019-2022 | |
| Mentor Worldwide LLC | $224.46 | 2020-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Galderma Laboratories, L.P. | $154.28 | 2019-2023 | |
| Motiva USA, LLC | $149.71 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $100.79 | 2019 | |
| Abbott Laboratories | $68.84 | 2022 | |
| Davol INC. | $39.18 | 2022 | |
| Axogen | $23.52 | 2020 | |
| Merz North America, INC. | $18.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roy Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.